About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Novel Pill Provides Natural Heart-Protecting Properties Found In Mediterranean Diet

by Aruna on September 2, 2009 at 8:56 AM
Font : A-A+

Novel Pill Provides Natural Heart-Protecting Properties Found In Mediterranean Diet

Scientists in Britain have developed a novel pill that would provide natural heart-protecting benefits of a Mediterranean diet.

Ateronon is believed to be the world's first compound to provide the natural heart-protecting antioxidant properties of the Mediterranean diet in a form that can be reliably absorbed by the human body.

Advertisement

Doctors from Cambridge University in England and Harvard medical school in America have initiated trials to investigate the properties of the treatment.

"We know the Mediterranean diet is beneficial in terms of lowering blood pressure and cholesterol levels, and the key element is tomatoes," the Telegraph quoted Ian Wilkinson, a British Heart Foundation-funded senior lecturer in clinical pharmacology at Cambridge University, as saying.
Advertisement

"We are hoping to build on that evidence and show that getting the whole food into people in higher concentrations might be more effective than just trying to give people one type of vitamin, or one type of dietary supplement," he added.

The key component of Ateronon is lycopene, which is derived from tomatoes, and promotes good cardiovascular health.

To date, it has been impossible to convert large lycopene crystals into smaller molecules more easily absorbed by humans.

Ateronon combines lycopene with a lactose-based milk protein, thus reducing the size of lycopene molecules and making them easier to absorb.

Lycopene is a powerful antioxidant that blocks the breakdown of fats in the blood, and leads to the release of cholesterol and low-density lipoproteins, which form fatty deposits on artery walls.

Howard Sesso, assistant professor of Medicine at the Brigham and Women's Hospital, part of Harvard University in Boston, is conducting a year-long research project involving 200 heart disease patients.

During the study, half of the patients will be given a dummy placebo pill for half of the trial period to ensure any identified Ateronon benefit can genuinely be attributed to the treatment itself.

Source: ANI
ARU
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Lung Transplantation
Baldness can be Cured and Prevented: let us see How!
Drinking Beer or Wine Every Day Could Cause Age-related Diseases
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diet Pills Drug Toxicity The Cabbage Diet Mediterranean Diet Negative Calorie Diet Vasectomy Bulimia Nervosa Why Do We Eat - Nutrition Facts Diet Lifestyle and Heart Disease Chickpea for the Soul! 

Most Popular on Medindia

The Essence of Yoga Noscaphene (Noscapine) Find a Doctor Selfie Addiction Calculator Pregnancy Confirmation Calculator Post-Nasal Drip Sinopril (2mg) (Lacidipine) Find a Hospital Loram (2 mg) (Lorazepam) Color Blindness Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use